The Perirenal Fat Thickness Was Associated with Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus

被引:4
|
作者
Yang, Yuxian [1 ]
Li, Shuting [1 ]
Xu, Yuechao [1 ]
Ke, Jing [1 ]
Zhao, Dong [1 ]
机构
[1] Capital Med Univ, Beijing Luhe Hosp, Ctr Endocrine Metab & Immune Dis, Beijing, Peoples R China
关键词
nonalcoholic fatty liver disease; perirenal fat thickness; paranephric fat thickness; type 2 diabetes mellitus; VISCERAL FAT; FIBROSIS; PREVALENCE; OBESITY; STEATOHEPATITIS; SEVERITY; RISK; LIPOTOXICITY; INFLAMMATION; MANAGEMENT;
D O I
10.2147/DMSO.S350579
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Obesity is an important risk factor for nonalcoholic fatty liver disease (NAFLD). Perirenal fat and paranephric fat were seldom studied in NAFLD. We aimed to explore the relationship between perirenal fat thickness (PrFT) and paranephric fat thickness (PnFT) and NAFLD in patients with type 2 diabetes mellitus (T2DM). Patients and Methods: A total of 493 diabetic patients including 231 NAFLD patients were enrolled in our study from September 2019 to December 2020. Patients with NAFLD were categorized into three subgroups according to the severity and fibrosis risk of NAFLD. Anthropometric indices and clinical characteristics were collected from clinical records. PrFT and PnFT were measured via ultrasound. Multivariate logistic regression analysis was used to assess the association between PrFT, PnFT and presence, severity and advanced fibrosis risk of NAFLD. Results: Compared with non-NAFLD patients, those with NAFLD had significantly higher PrFT and PnFT. The PrFT and PnFT were independently associated with presence of NAFLD and the PrFT was independently associated with the advanced fibrosis risk of NAFLD after adjusting confounding factors. Conclusion: The PrFT was independently associated with the presence and advanced fibrosis risk of NAFLD in patients with T2DM.
引用
收藏
页码:1505 / 1515
页数:11
相关论文
共 50 条
  • [41] Nonalcoholic Fatty Liver Disease Screening in Type 2 Diabetes Mellitus Patients in the Primary Care Setting
    Barbosa, Joana Vieira
    Lai, Michelle
    HEPATOLOGY COMMUNICATIONS, 2021, 5 (02) : 158 - 167
  • [42] Prevalence and risk factor analysis for the nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus
    Zhou, Qiumei
    Wang, Yulong
    Wang, Jiajia
    Liu, Yating
    Qi, Dehui
    Yao, Wei
    Jiang, Hui
    Li, Tingting
    Huang, Kaiquan
    Zhang, Wancun
    Huo, Xingxing
    MEDICINE, 2021, 100 (10)
  • [43] Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients
    Takashi Nakahara
    Hideyuki Hyogo
    Masato Yoneda
    Yoshio Sumida
    Yuichiro Eguchi
    Hideki Fujii
    Masafumi Ono
    Takumi Kawaguchi
    Kento Imajo
    Hiroshi Aikata
    Saiyu Tanaka
    Kazuyuki Kanemasa
    Kazuma Fujimoto
    Keizo Anzai
    Toshiji Saibara
    Michio Sata
    Atushi Nakajima
    Yoshito Itoh
    Kazuaki Chayama
    Takeshi Okanoue
    Journal of Gastroenterology, 2014, 49 : 1477 - 1484
  • [44] Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients
    Nakahara, Takashi
    Hyogo, Hideyuki
    Yoneda, Masato
    Sumida, Yoshio
    Eguchi, Yuichiro
    Fujii, Hideki
    Ono, Masafumi
    Kawaguchi, Takumi
    Imajo, Kento
    Aikata, Hiroshi
    Tanaka, Saiyu
    Kanemasa, Kazuyuki
    Fujimoto, Kazuma
    Anzai, Keizo
    Saibara, Toshiji
    Sata, Michio
    Nakajima, Atushi
    Itoh, Yoshito
    Chayama, Kazuaki
    Okanoue, Takeshi
    JOURNAL OF GASTROENTEROLOGY, 2014, 49 (11) : 1477 - 1484
  • [45] Circulating Levels of ELABELA Is Inversely Associated with Hepatic Fibrosis of Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus
    Shi, Min
    Cao, Huimin
    Liu, Yuting
    Gu, Wensha
    Zhang, Hong
    DIABETES, 2024, 73
  • [46] Low serum CTRP3 levels are associated with nonalcoholic fatty liver disease it in patients with type 2 diabetes mellitus
    Zhang, Junxia
    Zhang, Bilin
    Cheng, Yangyang
    Xu, Jinxiu
    CYTOKINE, 2018, 106 : 131 - 135
  • [47] Improvement of Nonalcoholic Fatty Liver Disease Reduces the Risk of Type 2 Diabetes Mellitus
    Cho, Hyo Jung
    Hwang, Sunhyuk
    Park, Jong Ik
    Yang, Min Jae
    Hwang, Jae Chul
    Yoo, Byung Moo
    Lee, Kee Myung
    Shin, Sung Jae
    Lee, Kwang Jae
    Kim, Jin Hong
    Cheong, Jae Youn
    Cho, Sung Won
    Kim, Soon Sun
    GUT AND LIVER, 2019, 13 (04) : 440 - 449
  • [48] Clinical Profile of Nonalcoholic Fatty Liver Disease in Adults with Type 2 Diabetes Mellitus
    Cusi, Kenneth
    Roden, Michael
    Barritt, Alfred S.
    Firpi, Roberto J.
    Clark, Virginia
    Klein, Samuel
    Lok, Anna
    Newsome, Philip
    Corbin, Karen
    Vos, Miriam B.
    Reddy, Rajender
    Schoen, Cheryl
    Mospan, Andrea R.
    Taunk, Jawahar L.
    Wyne, Kathleen
    Neuschwander-Tetri, Brent
    Sanyal, Arun
    DIABETES, 2020, 69
  • [49] Differential patterns of insulin secretion and sensitivity in patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease versus patients with type 2 diabetes mellitus alone
    Chai, Shang-Yu
    Pan, Xiao-Yu
    Song, Ke-Xiu
    Huang, Yue-Ye
    Li, Fei
    Cheng, Xiao-Yun
    Qu, Shen
    LIPIDS IN HEALTH AND DISEASE, 2014, 13
  • [50] Differential patterns of insulin secretion and sensitivity in patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease versus patients with type 2 diabetes mellitus alone
    Shang-Yu Chai
    Xiao-Yu Pan
    Ke-Xiu Song
    Yue-Ye Huang
    Fei Li
    Xiao-Yun Cheng
    Shen Qu
    Lipids in Health and Disease, 13